Brand / Product	Market	Holder	Status	Expires
ATACAND PLUS 16MG/12.5MG TABLETS	🇬🇭Ghana	—	active	Aug 2030
ATACAND PLUS 16MG/12.5MG TABLETS	🇬🇭Ghana	—	active	Aug 2030
Necsartan Tablets Tablet	🇳🇬Nigeria	Nectar Healthcare Limited	active	Dec 2028
Advantec Tablets 16 mg + 12.5 mg** Tablet	🇳🇬Nigeria	Getz Pharma Nigeria Limited	active	May 2028
CANDESAN PLUS TABLETS (Each tablet ccontains Candesartan Cilexetil/Hydrochlorothiazide 8mg/12.5mg)	🇬🇭Ghana	—	active	Jan 2027
CANDESAN PLUS TABLETS (Each tablet contains Candesartan Cilexetil/Hydrochlorothiazide 16mg/12.5mg)	🇬🇭Ghana	—	active	Jan 2027
CANDESAN PLUS TABLETS (Each tablet ccontains Candesartan Cilexetil/Hydrochlorothiazide 8mg/12.5mg)	🇬🇭Ghana	—	active	Jan 2027
CANDESAN PLUS TABLETS (Each tablet contains Candesartan Cilexetil/Hydrochlorothiazide 16mg/12.5mg)	🇬🇭Ghana	—	active	Jan 2027
Candesartan/HCT Sandoz 8 mg/12.5 mg Tablets (check pack size) Tablet	🇳🇬Nigeria	Novartis Nigeria Limited	active	Dec 2026
Atacand Plus 16/12.5 Tablets** Tablet	🇳🇬Nigeria	AstraZeneca Nigeria Limited	active	Oct 2026
Candesartan/HCT Sandoz 16 mg/12.5 mg Tablets** Tablet	🇳🇬Nigeria	Novartis Nigeria Limited	active	Feb 2026
PRESSCAND PLUS Comprimé sécable / 8 mg/12.5mg	🇹🇳Tunisia	PHARMACARE	expired	Apr 2022
PRESSCAND PLUS Comprimé sécable / 16 mg/12.5mg	🇹🇳Tunisia	PHARMACARE	expired	Apr 2022
PEMZEK PLUS Comprimé / 16 mg/12.5mg	🇹🇳Tunisia	AstraZeneca AG	expired	Jan 2022
PEMZEK PLUS Comprimé / 8 mg/12.5 mg	🇹🇳Tunisia	AstraZeneca AG	expired	Jan 2022
CANDESAR PLUS Comprimé / 16 mg/12.5 mg	🇹🇳Tunisia	DAR-ESSAYDALI.	expired	Jan 2021
CANDESAR PLUS Comprimé / 16 mg/12.5 mg	🇹🇳Tunisia	DAR-ESSAYDALI.	expired	Jan 2021
CANDESAR PLUS Comprimé / 8 mg/12.5 mg	🇹🇳Tunisia	DAR-ESSAYDALI.	expired	Jan 2021
CANDESAR PLUS Comprimé / 8 mg/12.5 mg	🇹🇳Tunisia	DAR-ESSAYDALI.	expired	Jan 2021
ARALEAD PLUS Comprimé pelliculé sécable / 8 mg/12.5mg	🇹🇳Tunisia	NEAPOLIS PHARMA	expired	Jul 2018
ARALEAD PLUS Comprimé pelliculé sécable / 8 mg/12.5mg	🇹🇳Tunisia	NEAPOLIS PHARMA	expired	Jul 2018
ARALEAD PLUS Comprimé pelliculé sécable / 16 mg/12.5mg	🇹🇳Tunisia	NEAPOLIS PHARMA	expired	Jul 2018
ARALEAD PLUS Comprimé pelliculé sécable / 16 mg/12.5mg	🇹🇳Tunisia	NEAPOLIS PHARMA	expired	Jul 2018
ETIKEN Comprimé sécable / 8 mg/12.5mg	🇹🇳Tunisia	TAHA PHARMA	expired	Dec 2015
ETIKEN Comprimé sécable / 16mg/12.5mg	🇹🇳Tunisia	TAHA PHARMA	expired	Dec 2015
ETIKEN Comprimé sécable / 16mg/12.5mg	🇹🇳Tunisia	TAHA PHARMA	expired	Jun 2015
ETIKEN Comprimé sécable / 8 mg/12.5mg	🇹🇳Tunisia	TAHA PHARMA	expired	Jun 2015
BLOPRESS 16 PLUS Comprimé / 16 mg/12.5 mg	🇹🇳Tunisia	IBN AL BAYTAR	expired	Jul 2011
BLOPRESS 8 PLUS Comprimé / 8 mg/12.5 mg	🇹🇳Tunisia	IBN AL BAYTAR	expired	Jul 2011
BLOPRESS 16 PLUS Comprimé / 16 mg/12.5 mg	🇹🇳Tunisia	APM	expired	Apr 2008
BLOPRESS 8 PLUS Comprimé / 8 mg/12.5 mg	🇹🇳Tunisia	APM	expired	Apr 2008
Aderan HTZ 8/12.5 Uncoated Tablets	🇹🇿Tanzania	Ajanta Pharma Limited	active	—
Aderan HTZ 16/12.5 Uncoated Tablets	🇹🇿Tanzania	Ajanta Pharma Limited	active	—
CANSAAR PLUS comprimé / 12,5 mg / 16 mg	🇸🇳Senegal	PHARMATEC PAKISTAN LIMITED	active	—
Atacand Plus Tablets	🇹🇿Tanzania	CHEPLAPHARM	active	—
HYTACAND comprimé / 8 mg / 12,5 mg	🇸🇳Senegal	ASTRA ZENECA	active	—

CANDESARTAN CILEXETIL / HYDROCHLOROTHIAZIDE in Africa — Regulatory Overview

CANDESARTAN CILEXETIL / HYDROCHLOROTHIAZIDE is registered across 5 African markets with 36 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Ghana, Nigeria, Tanzania and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 36 registrations, 16 (44%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.